Letter: Exfoliative dermatitis during treatment with pheneturide.
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D003873:Dermatitis, Exfoliative / Q000139:chemically induced* / Q000188:drug therapy; D004827:Epilepsy / Q000517:prevention & control; D006801:Humans; D008297:Male; D010634:Phenobarbital / Q000627:therapeutic use; D010654:Phenylbutyrates / Q000009:adverse effects; D010672:Phenytoin / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D014508:Urea / Q000009:adverse effects / Q000031:analogs & derivatives*
D000927:Anticonvulsants; D010654:Phenylbutyrates; D010672:Phenytoin; D014508:Urea; D011239:Prednisolone; D010634:Phenobarbital